Infectious Diseases Completed Phase 1 Trials for Relebactam (DB12377)

Also known as: Infectious Disease

IndicationStatusPhase
DBCOND0028267 (Infectious Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01275170A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005)Treatment